The medical device contract manufacturing market is poised to expand at a CAGR of 11.3% during the forecast period (2020-2026). This is attributed to rapidly evolving healthcare industry and increasing adoption of technologically advanced surgical procedures. A number of original equipment manufacturers (OEMs) and contract manufacturers have been focusing on advanced technologies such as robotics, 3D-printing, and minimally invasive surgeries. Mergers & acquisition activities among leading players have greatly accelerated the medical device contract manufacturing market growth.
The market is anticipated to experience a significant degree of downsizing amidst the coronavirus pandemic. This is because of the cessation of production due to stringent lockdowns to contain the spread of the virus. Fortunately, researchers and analysts are optimistic that medical devices will prove useful in diagnosing COVID-19 infections with greater precision compared to existing testing mechanisms. This is anticipated to keep market speculations high during the course of the pandemic.
To remain ‘ahead’ of your competitors, request for a sample >>> https://www.factmr.com/connectus/sample?flag=S&rep_id=4834
Key Takeaways of Medical Device Contract Manufacturing Market Study:
- Minimally access surgical instruments are anticipated to witness a strong growth in demand and increase at a CAGR of 10.6% over the forecast period.
- High popularity of minimally access surgical instruments is attributed to reduced tissue trauma, minimal blood loss and pain, greater affordability, and enhanced patient satisfaction.
- Contract manufacturing of electronic devices accounts for nearly half of the total market revenue. Increasing demand for patient monitoring and diagnostic devices across the globe is a major factor driving its growth.
- Finished device manufacturing remains highly preferred service, accounting for more than a quarter of the medical device contract manufacturing market value. A large number of market players offering finished products are expected to drive the segment’s growth.
- Contract manufacturing of orthopedic devices is expected to witness significant entry of key market players, attributed to rising incidence of arthritis amongst the geriatric population. Manufacturing of these devices is poised to capture over 1/4th of the total market value.
- North America will continue to maintain its hegemony in the global market, accounting for more than 40% of the revenue, while Asia-Pacific promises lucrative growth opportunities for market players, expanding at a CAGR of 10.8% through 2026.
- Stringent government regulations, rise in incidence of chronic conditions, strong focus on enhanced patient care, and adoption of minimally invasive procedures are prompting key players to enter both the regional markets.
“Booming healthcare industry has facilitated significant technological advancements in surgical procedures. These advancements have motivated key players to invest more in research & development of effective solutions, which in turn drives the medical device contract manufacturing market growth,” says the Fact.MR analyst.
Penetration in Developing Economies, Mergers & Acquisitions, and Product Launches to Determine Market Competition:
A large number of medical device contract manufacturers dominate the market. Prominent players in the medical device contract manufacturing market include: Integer Holdings Corporation, Flex Ltd., Jabil Inc., West Pharmaceutical, Inc., Benchmark Electronics, Inc., Tecomet, Inc., Nortech Systems, Inc., TE Connectivity, Forefront Medical Technologies and Nordson Corporation.These players are capitalizing on the growth potentials offered by emerging markets such as India, China and Brazil to consolidate their market footprints.
These countries promise immense growth opportunities due to a large population base and favorable business environments. For instance, Integer Holdings Corporation has more than 34 facilities across the U.S., six in Europe, 3 in Mexico, two in South East Asia and two in South Asia. Besides, the firm also offers a wide range of medical devices for orthopedic, cardiovascular and neuromodulation surgical procedures.
The companies also concentrate on mergers and acquisitions. For example, Jabil, Inc. entered into a strategic collaboration with Johnson & Johnson Medical Devices Companies in 2018. This collaboration is anticipated to expand Jabil’s medical devices manufacturing portfolio and offer diversification capabilities. Similarly, in March 2017, the company acquired Lewis Engineering for US$ 95.9 Mn, a firm which focuses on aerospace, semiconductor and medical machine components.
The COVID-19 pandemic has crippled major businesses across the world, halting production cycles and disrupting supply chains. The healthcare industry is facing immense challenges in eradicating the pandemic, as the number of infections show no signs of abatement. The medical device contract manufacturing market is anticipated to be impacted by the pandemic as the demand for medical devices for elective procedures has fallen. At the same time, the demand for medical devices such as ventilators and respirators has augmented, thereby influencing growth prospects for medical device manufacturers.
Players such as Integer Holdings have been constantly monitoring the situation since the pandemic’s onset. The company has ensured that there are minimal supply chain disruptions to their clients. To ensure safety, the company has implemented more rigorous cleaning and disinfection procedures; enforcing visitor guidance and screening; restricting business travel; setting up remote working arrangements and strict quarantine measures
Looking for more information?
The research study on the medical device contract manufacturing market by Fact.MR incorporates an unbiased assessment of key factors and trends responsible for shaping the landscape of the medical device technologies market over 2020-2026. It includes a detailed assessment of key parameters that are anticipated to exert influence during 2020-2026.
Market statistics have been presented on the basis of device (in-vitro diagnostic medical devices, diagnostic imaging & medical equipment, drug delivery devices, patient monitoring devices, minimally access surgical instruments, therapeutic patient assistive devices and others), type of manufacturing (raw materials, electronics and finished goods), services (prototype development, finished device manufacturing, assembly & packaging, testing & regulatory support services, molding & casting and others) and application (cardiovascular, orthopedic, neurovascular, pulmonary, oncology, laparoscopy, urology & gynecology, radiology and others) across five major regions.
Fact. MR’s Domain Knowledge in Healthcare
Fact .MR’s healthcare and research professionals guide organizations at each step of their business strategy by helping you understand how contemporary influencers impact transformation in the healthcare sector. Our expertise in recognizing the challenges and trends affecting the global healthcare industry provides valuable insight and support, helping identify critical issues and construct relevant solutions.
Fact.MR is an independent, pure play market intelligence firm incorporated with an objective to deliver high quality, customized market research solutions that help our clients successfully go to the market equipped with actionable insights capable of impacting crucial business decisions.
Unit No: AU-01-H Gold Tower (AU),Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai, United Arab Emirates
Ph. No: +353-1-6111-593